H18.049 Kayser-Fleischer ring, unspecified eye

Name of the Condition

• Kayser-Fleischer Ring, Unspecified Eye
• ICD Code: H18.049

Summary

Kayser-Fleischer ring, unspecified eye, is a brownish or greenish ring of copper deposition in the cornea, typically located at the limbus (the border between the cornea and sclera). This finding is a key clinical sign of Wilson disease, a genetic disorder affecting copper metabolism. The ring may be visible to the naked eye in advanced cases but is often detected via slit-lamp examination.

Causes

Kayser-Fleischer ring results from abnormal copper accumulation in the body due to impaired biliary excretion, a hallmark of Wilson disease. Copper deposits in the Descemet membrane of the cornea, forming the characteristic ring. The underlying cause is mutations in the ATP7B gene, which disrupts copper transport and elimination.

Risk Factors

• Genetic predisposition (family history of Wilson disease)
• Age (typically appears in late childhood or early adulthood)
• Untreated or poorly managed Wilson disease
• Lack of copper metabolism screening in at-risk individuals

Symptoms

• Often asymptomatic initially; may be detected during routine eye exams
• In advanced cases, potential visual disturbances (e.g., glare, blurred vision)
• Associated systemic symptoms of Wilson disease (e.g., liver dysfunction, neurological issues)

Diagnosis

Diagnosis involves slit-lamp examination to visualize the corneal ring. Additional tests, such as serum ceruloplasmin levels, 24-hour urinary copper excretion, and genetic testing for ATP7B mutations, help confirm Wilson disease. Imaging or liver biopsy may be used to assess systemic involvement.

Treatment Options

Treatment focuses on reducing copper levels and managing Wilson disease. Chelation therapy (e.g., penicillamine, trientine) or zinc supplements may be used to promote copper excretion or block absorption. Regular monitoring of copper levels and organ function is essential. In severe cases, liver transplantation may be necessary.

Prognosis and Follow-Up

With early diagnosis and treatment, prognosis is favorable, and symptoms may improve. Untreated Wilson disease can lead to progressive liver damage, neurological decline, or death. Lifelong follow-up is required to monitor copper levels, treatment efficacy, and organ function.

Complications

• Progressive liver cirrhosis or failure
• Neurological deterioration (e.g., tremors, cognitive changes)
• Hemolytic anemia
• Kidney damage

Lifestyle & Prevention

• Avoid copper-rich foods (e.g., shellfish, organ meats) if diagnosed with Wilson disease.
• Follow prescribed treatment regimens consistently.
• Genetic counseling for at-risk family members.
• Regular eye and systemic evaluations to monitor disease progression.

When to Seek Professional Help

Seek immediate medical attention if you experience unexplained visual changes, jaundice, abdominal pain, or neurological symptoms (e.g., difficulty walking, speech changes), as these may indicate Wilson disease or its complications.

Tips for Medical Coders

Use H18.049 for Kayser-Fleischer ring when the eye is not specified. Document the eye laterality (right, left, or bilateral) if known, as this may impact coding for related encounters. Ensure documentation supports the diagnosis and any associated systemic conditions (e.g., Wilson disease) for accurate code assignment.